About: Emedastine

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Emedastine (trade name Emadine) is a second generation antihistamine used in eye drops to alleviate the symptoms of allergic conjunctivitis. It acts as a H1 receptor antagonist. It works by blocking the action of histamine that causes allergic symptoms. It is used in form of the difumarate. The emedastine difumarate is a white, crystalline, water-soluble fine powder. Emedastine eye drops is usually applied twice a day to the affected eye. When the patients with allergic conjunctivitis were treated with 0.05% emedastine difumarate ophthalmic solution for six weeks, the signs and symptoms such as redness, itching and swelling of the eyes were relieved. Emedastine appears to be devoid of effects on adrenergic, dopaminergic and serotonin receptors. This drug was developed by Alcon, which is gl

Property Value
dbo:abstract
  • Emedastine (trade name Emadine) is a second generation antihistamine used in eye drops to alleviate the symptoms of allergic conjunctivitis. It acts as a H1 receptor antagonist. It works by blocking the action of histamine that causes allergic symptoms. It is used in form of the difumarate. The emedastine difumarate is a white, crystalline, water-soluble fine powder. Emedastine eye drops is usually applied twice a day to the affected eye. When the patients with allergic conjunctivitis were treated with 0.05% emedastine difumarate ophthalmic solution for six weeks, the signs and symptoms such as redness, itching and swelling of the eyes were relieved. Emedastine appears to be devoid of effects on adrenergic, dopaminergic and serotonin receptors. This drug was developed by Alcon, which is global medical company specializing in eye care products. (en)
  • エメダスチン(Emedastine)は第二世代の抗ヒスタミン薬である。商品名ダレン、レミカット。日本ではカプセル内用剤として市販されているが、海外では目薬としてアレルギー性結膜炎の治療に用いられている。H1受容体拮抗薬に分類され、アレルギー症状を引き起こすヒスタミンを遮断する事で効果を発揮する。アドレナリン受容体、ドーパミン受容体、セロトニン受容体には影響を与えないと思われる。製剤にはフマル酸塩が使用される。フマル酸塩の性状は白色の微細な結晶であり、水に溶け易い。 (ja)
  • Emedastyna (łac. emedastinum) – organiczny związek chemiczny, antagonista receptora H1 II generacji, stosowany w sezonowym alergicznym zapaleniu spojówek. (pl)
  • 依美斯汀(Emedastine,商品名稱: Emadine)是第二代抗組織胺,可用作眼藥水以減緩過敏性結膜炎的症狀。依美斯汀屬於H1 接收器抑制劑。藉由抑制組織胺的作用來減緩過敏性結膜炎的症狀。當依美斯汀用作眼藥水時,會以雙延胡索酸鹽(difumarate)的形式存在。 (zh)
dbo:casNumber
  • 87233-61-2
dbo:chemicalFormula
  • C17 H26 N4 O
dbo:fdaUniiCode
  • 9J1H7Y9OJV
dbo:thumbnail
dbo:wikiPageID
  • 4787359 (xsd:integer)
dbo:wikiPageLength
  • 4208 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1094528217 (xsd:integer)
dbo:wikiPageWikiLink
dbp:casNumber
  • 87233 (xsd:integer)
dbp:chemicalFormula
  • C17 H26 N4 O (en)
dbp:iupacName
  • 1 (xsd:integer)
dbp:unii
  • 9 (xsd:integer)
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • エメダスチン(Emedastine)は第二世代の抗ヒスタミン薬である。商品名ダレン、レミカット。日本ではカプセル内用剤として市販されているが、海外では目薬としてアレルギー性結膜炎の治療に用いられている。H1受容体拮抗薬に分類され、アレルギー症状を引き起こすヒスタミンを遮断する事で効果を発揮する。アドレナリン受容体、ドーパミン受容体、セロトニン受容体には影響を与えないと思われる。製剤にはフマル酸塩が使用される。フマル酸塩の性状は白色の微細な結晶であり、水に溶け易い。 (ja)
  • Emedastyna (łac. emedastinum) – organiczny związek chemiczny, antagonista receptora H1 II generacji, stosowany w sezonowym alergicznym zapaleniu spojówek. (pl)
  • 依美斯汀(Emedastine,商品名稱: Emadine)是第二代抗組織胺,可用作眼藥水以減緩過敏性結膜炎的症狀。依美斯汀屬於H1 接收器抑制劑。藉由抑制組織胺的作用來減緩過敏性結膜炎的症狀。當依美斯汀用作眼藥水時,會以雙延胡索酸鹽(difumarate)的形式存在。 (zh)
  • Emedastine (trade name Emadine) is a second generation antihistamine used in eye drops to alleviate the symptoms of allergic conjunctivitis. It acts as a H1 receptor antagonist. It works by blocking the action of histamine that causes allergic symptoms. It is used in form of the difumarate. The emedastine difumarate is a white, crystalline, water-soluble fine powder. Emedastine eye drops is usually applied twice a day to the affected eye. When the patients with allergic conjunctivitis were treated with 0.05% emedastine difumarate ophthalmic solution for six weeks, the signs and symptoms such as redness, itching and swelling of the eyes were relieved. Emedastine appears to be devoid of effects on adrenergic, dopaminergic and serotonin receptors. This drug was developed by Alcon, which is gl (en)
rdfs:label
  • Emedastine (en)
  • エメダスチン (ja)
  • Emedastyna (pl)
  • 依美斯汀 (zh)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License